IGF-1 C domain-modified hydrogel enhances cell therapy for acute kidney injury

• 来源期刊: 中国科学基金（英文版）
• 年，卷（期）: 2016,（3）
• 页码范围: 52
• 页数: 1页
• 语种: 英文

摘要

With the support by the National Natural Science Foundation of China and the Ministry of Science and Technology of China,Profs.Li Zongjin and Zhao Qiang (赵强) from the Innovative Research Team of Cardiovascular Tissue Engineering at Nankai University,in collaboration with Prof.Xu Yong at Tianjin Medical University,made new progress in developing IGF-1C modified chitosan hydrogel as stem cell carrier for the therapy of ischemic renal injury.The research result was published in J Am Soc Nephrol (2016,Feb 11,doi:10.1681/ASN.2015050578),which was accompanied by an editorial entitled "Modified hydrogels to enhance cellular therapy for acute kidney injury (AKI):a translational challenge".